| 发明名称 |
DOSAGE UNITS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D] [1,3] DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID |
| 摘要 |
The present invention relates to formulations of 3-(6-(1-(2,2-difluorobenzo [d][1,3 ]dioxol-5 -yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid in Form I, pharmaceutical packs or kits thereof, and methods of treatment therewith. |
| 申请公布号 |
US2016039800(A1) |
申请公布日期 |
2016.02.11 |
| 申请号 |
US201514920041 |
申请日期 |
2015.10.22 |
| 申请人 |
Vertex Pharmaceuticals Incorporated |
发明人 |
Young Christopher Ryan |
| 分类号 |
C07D405/12;A61K45/06;A61K31/443 |
主分类号 |
C07D405/12 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A dosage unit comprising 25 to 400 mg of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid characterized as Form I. |
| 地址 |
Boston MA US |
